Kawaguchi, K., Igarashi, K., Li, S., Han, Q., Tan, Y., Miyake, K., . . . Hoffman, R. M. (2017). Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse models. Oncotarget.
استشهاد بنمط شيكاغوKawaguchi, Kei, et al. "Recombinant Methioninase (rMETase) Is an Effective Therapeutic for BRAF-V600E-negative As Well As -positive Melanoma in Patient-derived Orthotopic Xenograft (PDOX) Mouse Models." Oncotarget 2017.
MLA استشهادKawaguchi, Kei, et al. "Recombinant Methioninase (rMETase) Is an Effective Therapeutic for BRAF-V600E-negative As Well As -positive Melanoma in Patient-derived Orthotopic Xenograft (PDOX) Mouse Models." Oncotarget 2017.